Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

725 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
HIV-Associated Venous Thromboembolism.
Bibas M, Biava G, Antinori A. Bibas M, et al. Among authors: antinori a. Mediterr J Hematol Infect Dis. 2011;3(1):e2011030. doi: 10.4084/MJHID.2011.030. Epub 2011 Jul 8. Mediterr J Hematol Infect Dis. 2011. PMID: 21869916 Free PMC article.
Presumptive clinical criteria versus endoscopy in the diagnosis of Candida esophagitis at various HIV-1 disease stages.
Antinori A, Antinori A, Ammassari A, Masetti R, De Luca A, Murri R, Tamburrini E, Magistrelli P. Antinori A, et al. Endoscopy. 1995 Jun;27(5):371-6. doi: 10.1055/s-2007-1005716. Endoscopy. 1995. PMID: 7588351
Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control study.
Ammassari A, Linzalone A, Murri R, Marasca G, Morace G, Antinori A. Ammassari A, et al. Among authors: antinori a. Scand J Infect Dis. 1995;27(3):235-7. doi: 10.3109/00365549509019015. Scand J Infect Dis. 1995. PMID: 8539547
Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey.
Murri R, Ammassari A, Fantoni M, Scoppettuolo G, Cingolani A, De Luca A, Damiano F, Antinori A. Murri R, et al. Among authors: antinori a. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 15;16(5):350-6. doi: 10.1097/00042560-199712150-00007. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9420313
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team.
Pontesilli O, Guerra EC, Ammassari A, Tomino C, Carlesimo M, Antinori A, Tamburrini E, Prozzo A, Seeber AC, Vella S, Ortona L, Aiuti F. Pontesilli O, et al. Among authors: antinori a. AIDS. 1998 Mar 26;12(5):473-80. doi: 10.1097/00002030-199805000-00008. AIDS. 1998. PMID: 9543445 Clinical Trial.
Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy.
Cingolani A, Antinori A, Sanguinetti M, Gillini L, De Luca A, Posteraro B, Ardito F, Fadda G, Ortona L. Cingolani A, et al. Among authors: antinori a. J Infect Dis. 1999 Apr;179(4):1025-9. doi: 10.1086/314677. J Infect Dis. 1999. PMID: 10068603
Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy.
De Luca A, Giancola ML, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A. De Luca A, et al. Among authors: antinori a. Clin Infect Dis. 1999 Mar;28(3):624-8. doi: 10.1086/515153. Clin Infect Dis. 1999. PMID: 10194089 Clinical Trial.
Role of brain biopsy in the management of focal brain lesions in HIV-infected patients. Gruppo Italiano Cooperativo AIDS & Tumori.
Antinori A, Ammassari A, Luzzati R, Castagna A, Maserati R, Rizzardini G, Ridolfo A, Fasan M, Vaccher E, Landonio G, Scerrati M, Rocca A, Butti G, Nicolato A, Lazzarin A, Tirelli U. Antinori A, et al. Neurology. 2000 Feb 22;54(4):993-7. doi: 10.1212/wnl.54.4.993. Neurology. 2000. PMID: 10691003 Clinical Trial.
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C, Pezzotti P, Govoni A, Borghi V, Antinori A, d'Arminio Monforte A, De Luca A, Mongiardo N, Cerri MC, Chiodo F, Concia E, Bonazzi L, Moroni M, Ortona L, Esposito R, Cossarizza A, De Rienzo B. Mussini C, et al. Among authors: antinori a. J Infect Dis. 2000 May;181(5):1635-42. doi: 10.1086/315471. Epub 2000 May 15. J Infect Dis. 2000. PMID: 10823763 Clinical Trial.
Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
De Luca A, Giancola ML, Cingolani A, Ammassari A, Murri R, Antinori A. De Luca A, et al. Among authors: antinori a. AIDS Res Hum Retroviruses. 2000 Jun 10;16(9):835-43. doi: 10.1089/08892220050042774. AIDS Res Hum Retroviruses. 2000. PMID: 10875609 Clinical Trial.
725 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback